Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does vitamin B6 deficiency slow homocysteine clearance?

Vitamin B6 deficiency significantly impairs homocysteine clearance by limiting the PLP-dependent transsulfuration enzymes that convert homocysteine to cysteine.

PlausibleJune 19, 202617 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Vitamin B6 deficiency can slow homocysteine clearance because pyridoxal phosphate is a cofactor for the transsulfuration enzymes that convert homocysteine toward cysteine.

laying out figure…
2 of 8 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that insufficient vitamin B6 reduces availability of pyridoxal 5′-phosphate (PLP), the required cofactor for CBS and CSE, and thereby slows the transsulfuration pathway. Mechanistically, PLP loss decreases enzyme activity and often creates a bottleneck at the CSE step, causing cystathionine accumulation and reduced conversion of homocysteine to cysteine, a problem that is most apparent after protein or methionine intake.

Verified conclusion

Vitamin B6 deficiency significantly impairs the body's ability to clear homocysteine, an effect driven by the loss of essential enzymatic cofactors within the transsulfuration pathway. This pathway is a critical metabolic route for the permanent disposal of homocysteine.

Clinical and metabolic evidence

The transsulfuration pathway accounts for a major portion of homocysteine disposal, particularly following meals. Research indicates that vitamin B6 deficiency reduces the efficiency of this clearance, leading to elevated levels of homocysteine (hyperhomocysteinemia).

  • Postprandial sensitivity: While fasting homocysteine levels are often maintained by folate- and B12-dependent remethylation, the transsulfuration pathway is the primary route for clearing excess homocysteine after protein intake. Methionine load tests demonstrate that vitamin B6-deficient individuals show significantly higher and more prolonged elevations of homocysteine compared to those with adequate B6 levels.
  • Aging considerations: In older populations, vitamin B6 status is often compromised. Studies in elderly women (matching your context) have shown that even marginal B6 deficiency leads to a measurable decrease in transsulfuration flux, increasing the risk of cardiovascular and cognitive issues associated with high homocysteine.

Mechanistic explanations

The link between vitamin B6 and homocysteine clearance is purely biochemical, rooted in the requirement for pyridoxal 5′-phosphate (PLP), the active form of B6, as a catalytic cofactor.

  • The PLP-dependent enzymes: Two specific enzymes require PLP to function:
    • Cystathionine β-synthase (CBS): This enzyme catalyzes the first step, condensing homocysteine with serine to form cystathionine.
    • Cystathionine γ-lyase (CSE): This enzyme catalyzes the second step, cleaving cystathionine into cysteine and α-ketobutyrate.
  • Differential sensitivity: Evidence shows that CSE is particularly sensitive to PLP depletion. During B6 deficiency, a "bottleneck" often occurs at the CSE step; while some homocysteine is converted to cystathionine, the pathway stalls there, preventing the final conversion to cysteine and slowing the overall clearance of homocysteine from the system.
  • Regulatory roles: Beyond basic catalysis, PLP facilitates the formation of Schiff-base intermediates that stabilize the chemical reactions necessary for sulfur-group transfer. Additionally, in mammals, the activity of the CBS enzyme is allosterically regulated by S-adenosylmethionine (SAM), which signals the enzyme to increase homocysteine clearance when methionine levels are high.

Bottom line

Vitamin B6 deficiency slows homocysteine clearance because the active form of B6 (PLP) is the mandatory cofactor for the enzymes CBS and CSE. Without sufficient PLP, these enzymes cannot effectively convert homocysteine into cysteine, leading to metabolic bottlenecks and elevated homocysteine levels, especially after protein-rich meals.

References

  1. The effect of a subnormal vitamin B-6 status on homocysteine metabolism. — pmc.ncbi.nlm.nih.gov ↗
  2. Vitamin B6 nutritional status and cellular availability of pyridoxal 5'-phosphate govern the function of the transsulfuration pathway's canonical reactions and hydrogen sulfide production via side reactions. — pmc.ncbi.nlm.nih.gov ↗
  3. Vitamin B6 deficiency, genome instability and cancer. — koreascience.or.kr ↗
  4. Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature. — pmc.ncbi.nlm.nih.gov ↗
  5. Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria. — pmc.ncbi.nlm.nih.gov ↗
  6. PLP-dependent H(2)S biogenesis. — pmc.ncbi.nlm.nih.gov ↗
  7. Functional Properties of the Active Core of Human Cystathionine β-Synthase Crystals* — jbc.org ↗
  8. Catalytic specificity of the Lactobacillus plantarum cystathionine γ-lyase presumed by the crystallographic analysis — pmc.ncbi.nlm.nih.gov ↗
  9. A Clinically Relevant Variant of the Human Hydrogen Sulfide-Synthesizing Enzyme Cystathionine β-Synthase: Increased CO Reactivity as a Novel Molecular Mechanism of Pathogenicity? — onlinelibrary.wiley.com ↗
  10. Elucidating the Heme Domain's Regulatory Role on Human Cystathionine β‐Synthase (hCBS) Product Formation — faseb.onlinelibrary.wiley.com ↗
  11. The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues. — pmc.ncbi.nlm.nih.gov ↗
  12. Vitamin B6 Nutritional Status and Cellular Availability of Pyridoxal 5’-Phosphate Govern the Function of the Transsulfuration Pathway’s Canonical Reactions and Hydrogen Sulfide Production via Side Reactions — linkinghub.elsevier.com ↗
  13. Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria. — link.springer.com ↗
  14. Structural basis of regulation and oligomerization of human cystathionine β-synthase, the central enzyme of transsulfuration — pnas.org ↗
  15. Allosteric Communication between the Pyridoxal 5′-Phosphate (PLP) and Heme Sites in the H2S Generator Human Cystathionine β-Synthase* — pmc.ncbi.nlm.nih.gov ↗
  16. Heme regulation of human cystathionine beta-synthase activity: insights from fluorescence and Raman spectroscopy. — pmc.ncbi.nlm.nih.gov ↗
  17. Pyridoxal phosphate binding sites are similar in human heme-dependent and yeast heme-independent cystathionine beta-synthases. Evidence from 31P NMR and pulsed EPR spectroscopy that heme and PLP cofactors are not proximal in the human enzyme. — linkinghub.elsevier.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→